Srinivas N. Pentyala
Director/Miembro de la Junta en Translational Research Group, Inc. .
Perfil
Srinivas N.
Pentyala is a Director of Affinimark Technologies, Inc. He is a Faculty Member of Anesthesiology, Urology, Health sciences, Physiology, and Biophysics at the Medical School of the State University of New York.
Dr. Pentyala is a Director for Translational Research.
He is a Course Director for the New York State Center for Biotechnology.
Dr. Pentyala worked as a Professor and Faculty Member at Stony Brook University.
He holds a PhD.
Cargos activos de Srinivas N. Pentyala
Empresas | Cargo | Inicio |
---|---|---|
The State University of New York | Corporate Officer/Principal | - |
Translational Research Group, Inc. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Srinivas N. Pentyala.
Empresas | Cargo | Fin |
---|---|---|
Stony Brook University | Corporate Officer/Principal | - |
Affinimark Technologies, Inc.
Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Affinimark Technologies, Inc.
Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Health Technology |
Translational Research Group, Inc. |
- Bolsa de valores
- Insiders
- Srinivas N. Pentyala